Navigation Links
Evotec Reports Positive Proof-of-Concept Top-Line Results with,Insomnia Drug Candidate EVT 201

Both Co-Primary Endpoints, Wake After Sleep Onset and Total Sleep Time, and Key Secondary Endpoints, Including Latency to Persistent Sleep, Were Met at Both Doses

HAMBURG, Germany and OXFORD, England, June 04, 2007 /PRNewswire-FirstCall/ -- Evotec AG announced today positive top-line results from its first phase II clinical trial of EVT 201 in patients with chronic primary insomnia. EVT 201 is a partial positive allosteric modulator (pPAM) of the GABAA receptor complex. The double-blinded, placebo controlled cross-over study design of two doses of EVT 201 (1.5mg and 2.5mg) in 67 patients was conducted in sleep labs in the US using objective polysomnography. The pre-specified intention-to-treat analysis of the study showed statistically highly significant improvements between both doses of EVT 201 and placebo in both of the co-primary endpoints of Total Sleep Time (TST) (p<0.001) and Wake After Sleep Onset (WASO) (p<0.001). Notably, WASO during the second half of the night was also significantly (p<0.001) reduced, indicating that EVT 201 has efficacy in sleep maintenance throughout the night.

Improvements were also seen across pre-specified secondary endpoints. Latency to persistent sleep was markedly decreased by both doses of EVT 201 (p<0.001) and patients reported highly significant improvements in subjectively assessed quality of sleep (p<0.001 both doses). Treatment with EVT 201 was completely without effect on subjectively assessed residual sedation the next day and produced only a small decremental effect on the digital symbol substitution test (DSST) assessed at nine hours post dosing. Initial analysis showed that EVT 201 did not impair slow wave sleep unlike many benzodiazepine full agonists. The study therefore demonstrated EVT 201 has robust effects on both sleep onset and sleep maintenance and is without meaningful next day hang-over effects.

EVT 201 was demonstrated to be safe and well
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Evotec AG (DE) - Evotec Reports Positive Proof-of-Concept Top-Line Results with ...
2. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
3. Cobalis Reports Phase III Trial Results for PreHistin in Seasonal Allergic Rhinitis
4. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
5. Cytos Biotechnology Reports Results from Phase IIa Study with CYT003-QbG10 in Patients Suffering from Atopic Dermatitis
6. Cytokinetics Reports Additional Clinical Trials Data for Ispinesib
7. The European Myeloma Platform Reports New Survival data for Revlimid Presented at the International Myeloma Workshop in Greece
8. Cytochroma Reports Positive Phase I Clinical Data for CTA018 Injection
9. Speedel Reports Successful SPP635 Phase IIa Trial in Hypertension
10. Columbia Laboratories Reports Positive Results from Multi-dose Pharmacokinetic Study of Vaginally-administered Lidocaine
11. CytRx Reports Promising Data from Its Open-Label Extension Clinical Trial of Arimoclomol in ALS
Post Your Comments:
(Date:5/20/2008)...lative therapy with HALO device leads to 100% pati..., SUNNYVALE, Calif., May 20 /- BARRX...ting Barrett,s esophagus, today announced the,publ...t a 100% eradication,rate for early esophageal can...esection followed by ablation therapy with the HAL...
(Date:5/20/2008)...N, May 20 /PRNewswire-USNewswire/ -- Fuisz Tobacco...cal study comparing the,absorption of nicotine fro...rip and the use of a nicotine 2mg chewing gum -- t...com/cgi-bin/prnh/20080115/CLTU066 ), The results...y for the,Fuisz Tobacco strip. A Fuisz Tobacco str...
(Date:5/19/2008)..., Md., May 19 /PRNewswire-USNewswire/ -- On Thursd...mpany of the Year at the annual,Technology Council...e,state,s technology leaders and organizations., ... , "All the members of the Sanaria team go to wor... a vaccine that will prevent millions of deaths,fr...
(Date:5/19/2008)...her with Nektar Therapeutics present preliminary P... pneumonia in intubated and mec..., May 19 /- Bayer HealthCar... ), today presented positive,preliminary Phase II ...cin,Inhale at the American Thoracic Society (ATS) ...
Breaking Medicine Technology:Early Esophageal Cancer and Pre-Cancer Eliminated With Non-Surgical Treatment Combination 2Early Esophageal Cancer and Pre-Cancer Eliminated With Non-Surgical Treatment Combination 3Fuisz Tobacco Announces Clinical Study Results for Fuisz Tobacco Sheet Strip; Super Enhanced Bioavailability of Nicotine From Its Tobacco Sheet Strip Supports Efficacy of Low Dose Tobacco Product 2Fuisz Tobacco Announces Clinical Study Results for Fuisz Tobacco Sheet Strip; Super Enhanced Bioavailability of Nicotine From Its Tobacco Sheet Strip Supports Efficacy of Low Dose Tobacco Product 3Malaria Vaccine Developer Sanaria Inc. Receives the Technology Council of Maryland's Emerging Company of the Year Award 2Amikacin Inhale Shows Promising Results in Phase II Study 2Amikacin Inhale Shows Promising Results in Phase II Study 3Amikacin Inhale Shows Promising Results in Phase II Study 4Amikacin Inhale Shows Promising Results in Phase II Study 5Amikacin Inhale Shows Promising Results in Phase II Study 6Amikacin Inhale Shows Promising Results in Phase II Study 7Plastic Surgery 2007 3A Where Truth Behind Emerging Cosmetic Treatments Meets Amazing Reconstructive Advances 2112 1Plastic Surgery 2007 3A Where Truth Behind Emerging Cosmetic Treatments Meets Amazing Reconstructive Advances 2112 2Plastic Surgery 2007 3A Where Truth Behind Emerging Cosmetic Treatments Meets Amazing Reconstructive Advances 2112 3Medical University of South Carolina Leads Multicenter Study Evaluating Biliary Sphincter Disorder 2108 1Medical University of South Carolina Leads Multicenter Study Evaluating Biliary Sphincter Disorder 2108 2Kiwa Bio Tech Completes 1st Stage of Shandong Factory Upgrading 859 1Kiwa Bio Tech Completes 1st Stage of Shandong Factory Upgrading 859 2Engineered eggshells to help make hydrogen fuel 575 1Engineered eggshells to help make hydrogen fuel 575 2Engineered eggshells to help make hydrogen fuel 575 3
(Date:5/20/2008)...adrenal masses seen on abdominal CT scans of low-r...eed any imaging follow-up, according to a large st...use incidental adrenal lesions are seen in about 5...tudy included 973 patients with 1,049 adrenal mass...uspicion of a hormonally active adrenal mass, said...
(Date:5/20/2008)... clinical settings, DNA microarrays are currently ...ion on formalin-fixed paraffin-embedded tissues is...lar markers for identifying the prognosis of gastr... a team led by Professor Zhong-Sheng Zhao, is desc...il 7, 2008 in the World Journal of Gastroenterolog...
(Date:5/20/2008)...doscopy is a well accepted tool for evaluation of ...However, it has some limitations due to restricted...residual material. Several forms of preparation (e...nts) have been tried to improve the quality of the...tocol has been recommended for bowel preparation f...
(Date:5/20/2008)...orectal signet ring cell carcinoma is a rare but d...n 96% of signet ring cell carcinomas arise in the ...organs. Therefore, a secondary infiltration or met...efore a definite diagnosis of primary colorectal s...This research, performed by a team led by Professo...
Breaking Medicine News(10 mins):Health News:How does sodium phosphate combined with bisacodyl affect small intestine? 2
...t attack or stroke victims to bust blood clots may...f amputation, according to a study published Monda...are has grown significantly in the last 25 years, ...ombating frostbite, say the authors of the article...
...p to support film/television actress Fran Drescher...ealed that the actress will be backing her Cancer ...e on the movement', Contactmusic quoted Drescher, ...eline Bertrand fought a cancer battle for seven an...
...recently starred in 'Ocean's 13' did not scold her... of marijuana because she used to smoke it with h...e the incident even though she knew he was indulgi...ports contactmusic.com. She says: 'I used to smok...
... come as a boon for cancer patients who have to sp...Like in the case of Nick Gall-Tomassen, aged 31, ...is recuperation time away from the ward. His back... feed straight into his body through a vein in his...
Other Medicine News:Health News:Frostbite can Be Treated by Bloodclot Drug 2Health News:Special Backpacks Provide Much Needed Relief for Cancer Patients 2
...rence laboratory and a worldwide leader in innovat...rs an extensive test menu of highly complex and un...ogy. Owned by the University of Utah, ARUP Laborat...n's university teaching hospitals and children's h...
...rence laboratory and a worldwide leader in innovat...rs an extensive test menu of highly complex and un...ogy. Owned by the University of Utah, ARUP Laborat...n's university teaching hospitals and children's h...
...rence laboratory and a worldwide leader in innovat...rs an extensive test menu of highly complex and un...ogy. Owned by the University of Utah, ARUP Laborat...n's university teaching hospitals and children's h...
...rence laboratory and a worldwide leader in innovat...rs an extensive test menu of highly complex and un...ogy. Owned by the University of Utah, ARUP Laborat...n's university teaching hospitals and children's h...
Medicine Products: